TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
66.87
66.87
Year Range
23.30
69.20
Daily Change
-3.13%
Monthly Change
+16.30%
6 month change
+114.05%
Year Change
+133.73%
Previous Close
69.0 3
Open
66.8 7
Low
66.8 7
High
66.8 7
Volume
165
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-21.65
Price to sales ratio
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

News